Biotech leader Stoke Therapeutics STOK offers a new buy point following a big rebound in recent weeks. That makes Stoke stock Tuesday's pick for IBD 50 Growth Stocks To Watch.

Stoke Therapeutics, Inc.'s zorevunersen shows strong efficacy in Dravet syndrome, earning FDA Breakthrough Therapy designation and driving a major stock rebound in recent months. A lucrative Biogen ...

Detailed price information for Stoke Therapeutics Inc (STOK-Q) from The Globe and Mail including charting and trades.

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational ...

The MarketWatch News Department was not involved in the creation of this content. Thomas Tull's USIT leads round to support Stoke's mission to strengthen resilience and competition across the U.S.